Skip to content

Alpha Cognition ACOG Other accrued liabilities

Other accrued liabilities at other companies

Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's other accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's other accrued liabilities?
Alpha Cognition (ACOG) reported other accrued liabilities of $944.59K in Q1 2026.
How has Alpha Cognition's other accrued liabilities changed year-over-year?
Alpha Cognition's other accrued liabilities decreased by 25.6% year-over-year, from $1.27M to $944.59K.
What is the long-term trend for Alpha Cognition's other accrued liabilities?
Over 2 years (2023 to 2025), Alpha Cognition's other accrued liabilities has grown at a 253.8% compound annual growth rate (CAGR), from $127.28K to $1.59M.